Incyte to Ring NASDAQ Stock Market Opening Bell in Support of Blood Cancer
*Live Webcast Available Starting at 9:15 am ET
*Incyte Launches ‘Voices of MPN’ Initiative to Unite, Connect and Support
Community Affected by Rare Blood Cancers: Myeloproliferative Neoplasms
WILMINGTON, Del. -- September 3, 2013
Incyte Corporation (Nasdaq:INCY) will ring the opening bell at the NASDAQ
MarketSite today to support the start of Blood Cancer Awareness Month and the
launch of Voices of MPN™, a new community awareness initiative to unite,
connect and support people living with myeloproliferative neoplasms (MPNs), a
group of rare and progressive blood cancers that includes myelofibrosis,
polycythemia vera and essential thrombocythemia.^1 September 12 has been
designated the inaugural MPN Awareness Day.
Incyte President and Chief Executive Officer Paul A. Friedman, M.D. will
perform the honorary bell ringing ceremony today from 9:15 to 9:30 a.m. ET. A
live webcast will be available at
http://www.nasdaq.com/about/marketsitetowervideo.asx. Dr. Friedman will be
joined by members of the Incyte leadership team and the patient advocacy
“Incyte is committed to making a difference in the lives of patients with
cancer,” stated Dr. Friedman. “We ring the NASDAQ opening bell today alongside
the MPN community to mark the start of blood cancer awareness month and bring
attention to rare blood cancers, like MPNs. We are simultaneously launching a
new initiative that is intended to increase awareness of MPNs and encourage
members of the community to join together and raise their voices in support.”
Voices of MPN invites all members of the MPN community, including patients,
advocacy organizations, and health care professionals to engage in a variety
of events designed to help raise the voices of individuals affected by MPNs.
The Voices of MPN website links people to disease information, educational
programs and community activities, while inviting them to share their stories.
A Wall of Voices (a virtual wall of recognition) invites a person to submit
pictures and a few lines of testimony about an individual or organization who
has touched the lives of those impacted by MPNs. Voices of MPN Facebook,
YouTube and Pinterest pages invite people to learn more about MPNs and help
spread awareness through social media sharing.
In conjunction with the initiative, Incyte is calling for nominations for “MPN
Heroes: Recognizing the Champions Among Us,” a program to recognize
individuals and organizations who have provided health care above and beyond
the standard of care, demonstrated outstanding commitment, provided leadership
to the community, or advanced science for MPNs. To learn more about MPN
Heroes, visit www.MPNHeroes.com.
To learn more about Voices of MPN, visit www.VoicesofMPN.com.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company
focused on the discovery, development and commercialization of proprietary
small molecule drugs for oncology and inflammation. For additional information
on Incyte, please visit the Company's website at www.incyte.com.
^1 “Learning About MPNs,” MPN Research Foundation,
Pamela M. Murphy, 302-498-6944
Vice President, Investor Relations & Corporate Communications
Sam Brown Inc.
Mariesa Kemble, 608-850-4745 (Media)
Press spacebar to pause and continue. Press esc to stop.